Stress and Gingival Inflammation in Non-pregnant and Pregnant Women

Periodontal Diseases Clinical Trial

Official title:

Effect of Non-Surgical Periodontal Therapy on Pregnancy-Related Degree of Gingival Inflammation and Stress Markers

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03336957
• Other study ID #: 15-KAEK-154
• Status: Completed
• Phase: N/A
• First received: November 2, 2017
• Last updated: November 6, 2017
• Start date: June 1, 2016
• Est. completion date: January 1, 2017

Study information

• Verified date: November 2017
• Source: Tokat Gaziosmanpasa University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Background: The purpose of the present study is to research whether stress scale scores alter with relationship to gingival inflammation and examine the impact of non-surgical periodontal therapy during pregnancy on the levels of cytokines in gingival crevicular fluid (GCF) and on salivary stress-related hormones.

Methods: 30 non-pregnant (control group) and 30 pregnant women (test group) who fulfilled the study inclusion criteria were chosen. The participants with moderate/severe gingivitis were included. Clinical data and samples of GCF and salivary were collected at baseline and after periodontal therapy. The levels of cytokines interleukin-1 beta (IL-1β) and IL-10, and concentration of salivary chromogranin A (Cg A) hormone were analyzed by enzyme-linked immunosorbent assay kits.

Description:

Periodontal clinical measurements and periodontal treatment were applied by a previously trained and calibrated examiner. Clinical parameters measurements including; probing pocket depths (PPD; the distance from the gingival margin to the base of the gingival sulcus), clinical attachment level (CAL), full mouth gingival index (GI)21 and plaque index (PI)20 scores using a periodontal probe were registered following saliva and GCF sample collection. Then, non-surgical periodontal therapy (NPT) consisted of scaling, root planning, and oral hygiene instruction was applied. Clinical measurements, recruitment of GCF, and saliva samples were repeated after three weeks.

Gingival Crevicular Fluid and Saliva Sample Collection Selected anterior teeth for GCF sampling were isolated from saliva using cotton rolls, a gentle stream of air was conducted parallel to the root surface for 5 to 10 seconds to dry the area.

The periopaper strips were gently inserted into the gingival crevice until resistance was felt and were left in place for 30 s and were collected from mesio-buccal sulcus of teeth in the anterior region of each patient (two samples per patient and per visit). The samples containing blood were discarded and were placed in sterile Eppendorf tubes and were stored at -20°C until the assay procedure.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 2
• Est. completion date: January 1, 2017
• Est. primary completion date: January 1, 2017
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Female
• Age group: 20 Years to 45 Years

Eligibility

Inclusion Criteria:

1. Must be systemically healthy;

2. Must be at least twenty teeth in the mouth;

3. Clinical diagnosis of gingivitis;

4. Must be the probing pocket depth (PPD)=3 mm in all four quadrants.

Exclusion Criteria:

• the use of anti-inflammatory,

• antimicrobial and hormone therapy within the preceding 6 months,

• having psychiatric disorders,

• a systemic disease,

• smoking cigarettes and

• for the control group breastfeeding, pregnancy and menstrual periods.

Related Conditions & MeSH terms

• Gingival Diseases
• Gingivitis
• Inflammation
• Periodontal Diseases
• Pregnancy Gingivitis

Intervention

Procedure:
• periodontal treatment
non-surgical periodontal therapy (NPT) consisted of scaling, root planning, and oral hygiene instruction

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
Tokat Gaziosmanpasa University

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	salivary Cg A hormone concentration	Samples should be taken before and after treatment and evaluated using ELISA kits	up to 8 weeks
Secondary	IL-1ß and IL-10 Cytokine levels in the GCF	Samples should be taken before and after treatment and evaluated using ELISA kits	up to 8 weeks